Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Int J Mol Sci ; 22(15)2021 Aug 02.
Artículo en Inglés | MEDLINE | ID: mdl-34361073

RESUMEN

This study evaluated the immunonutritional effects caused by protease inhibitors from Avena sativa and Triticum durum to human macrophage-like cells. Macrophages were exposed (3 h) to extracts obtained from flours, and mitochondrial-associated oxygen consumption rates and inflammatory, metabolic, and proteome adaptations were quantified. Mass spectrometry 'm/z' signals of the extracts obtained from T. durum and A. sativa revealed molecular weights of 18-35 kDa and 16-22 kDa, respectively, for the compounds present at highest concentrations. Extracts from T. durum exhibited lower susceptibility to degradation by gastrointestinal enzymes than those from A. sativa: 9.5% vs 20.2%. Despite their different botanical origin, both extracts increased TLR4 expression. Metabolic protein levels were indicative of a decreased glycolytic to lactate flux in cell cultures upon stimulation with A. sativa extracts, which improved mitochondrial respiration in relation to those from T. durum. Principal components analysis confirmed relative similarities between immune-metabolic events triggered by immunonutritional ingredients in T. durum and A. sativa. Collectively, immunonutritional effects help to interpret the differences between both crops, worsening or improving, macrophage immune reactivity (tolerogenicity), and better control of inflammatory processes.


Asunto(s)
Avena/química , Macrófagos/inmunología , Macrófagos/metabolismo , Extractos Vegetales/farmacología , Inhibidores de Proteasas/farmacología , Proteoma/efectos de los fármacos , Triticum/química , Humanos , Macrófagos/efectos de los fármacos
2.
Nutrients ; 12(7)2020 Jun 30.
Artículo en Inglés | MEDLINE | ID: mdl-32629893

RESUMEN

Complex interactions between immunonutritional agonist and high fat intake (HFD), the immune system and finally gut microbiota are important determinants of hepatocarcinoma (HCC) severity. The ability of immunonutritional agonists to modulate major aspects such as liver innate immunity and inflammation and alterations in major lipids profile as well as gut microbiota during HCC development is poorly understood. 1H NMR has been employed to assess imbalances in saturated fatty acids, MUFA and PUFA, which were associated to variations in iron homeostasis. These effects were dependent on the botanical nature (Chenopodium quinoa vs. Salvia hispanica L.) of the compounds. The results showed that immunonutritional agonists' promoted resistance to hepatocarcinogenesis under pro-tumorigenic inflammation reflected, at a different extent, in increased proportions of F4/80+ cells in injured livers as well as positive trends of accumulated immune mediators (CD68/CD206 ratio) in intestinal tissue. Administration of all immunonutritional agonists caused similar variations of fecal microbiota, towards a lower obesity-inducing potential than animals only fed a HFD. Modulation of Firmicutes to Bacteroidetes contents restored the induction of microbial metabolites to improve epithelial barrier function, showing an association with liver saturated fatty acids and the MUFA and PUFA fractions. Collectively, these data provide novel findings supporting beneficial immunometabolic effects targeting hepatocarcinogenesis, influencing innate immunity within the gut-liver axis, and providing novel insights into their immunomodulatory activity.


Asunto(s)
Carcinoma Hepatocelular/inmunología , Chenopodium quinoa , Neoplasias Hepáticas/inmunología , Fenómenos Fisiológicos de la Nutrición/inmunología , Extractos Vegetales/farmacología , Salvia , Animales , Antígenos CD/metabolismo , Antígenos de Diferenciación Mielomonocítica/metabolismo , Bacteroidetes , Carcinoma Hepatocelular/microbiología , Dieta Alta en Grasa/efectos adversos , Grasas de la Dieta/inmunología , Ácidos Grasos/inmunología , Firmicutes , Microbioma Gastrointestinal/inmunología , Inmunidad Innata/efectos de los fármacos , Inflamación , Mucosa Intestinal/inmunología , Intestinos/inmunología , Lectinas Tipo C/metabolismo , Hígado/inmunología , Neoplasias Hepáticas/microbiología , Masculino , Receptor de Manosa , Lectinas de Unión a Manosa/metabolismo , Ratones , Receptores de Superficie Celular/metabolismo , Semillas
3.
Nutrients ; 11(5)2019 May 25.
Artículo en Inglés | MEDLINE | ID: mdl-31130634

RESUMEN

Plant-derived food consumption has gained attention as potential intervention for the improvement of intestinal inflammatory diseases. Apple consumption has been shown to be effective at ameliorating intestinal inflammation symptoms. These beneficial effects have been related to (poly)phenols, including phloretin (Phlor) and its glycoside named phloridzin (Phldz). To deepen the modulatory effects of these molecules we studied: i) their influence on the synthesis of proinflammatory molecules (PGE2, IL-8, IL-6, MCP-1, and ICAM-1) in IL-1ß-treated myofibroblasts of the colon CCD-18Co cell line, and ii) the inhibitory potential of the formation of advanced glycation end products (AGEs). The results showed that Phlor (10-50 µM) decreased the synthesis of PGE2 and IL-8 and the formation of AGEs by different mechanisms. It is concluded that Phlor and Phldz, compounds found exclusively in apples, are positively associated with potential beneficial effects of apple consumption.


Asunto(s)
Colon/efectos de los fármacos , Frutas/química , Inflamación/metabolismo , Malus/química , Floretina/farmacología , Florizina/farmacología , Extractos Vegetales/farmacología , Antiinflamatorios/farmacología , Antiinflamatorios/uso terapéutico , Línea Celular , Colon/metabolismo , Colon/patología , Dieta , Dinoprostona/metabolismo , Productos Finales de Glicación Avanzada/metabolismo , Humanos , Inflamación/dietoterapia , Inflamación/tratamiento farmacológico , Enfermedades Inflamatorias del Intestino/dietoterapia , Enfermedades Inflamatorias del Intestino/tratamiento farmacológico , Enfermedades Inflamatorias del Intestino/metabolismo , Molécula 1 de Adhesión Intercelular/metabolismo , Interleucina-1beta , Interleucina-6/metabolismo , Interleucina-8/metabolismo , Floretina/uso terapéutico , Florizina/uso terapéutico , Fitoquímicos/farmacología , Fitoquímicos/uso terapéutico , Fitoterapia , Extractos Vegetales/uso terapéutico , Polifenoles/farmacología , Polifenoles/uso terapéutico , Receptores CCR2/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA